GlobalData on MSN9h
Roche secures CE mark for ovarian cancer detection test
Roche has secured CE mark approval for its immunohistochemistry (IHC) companion diagnostic test, VENTANA FOLR1 (FOLR1-2.1) ...
360dx5h
Roche IHC Assay Nabs CE Mark as Companion Diagnostic for Abbvie's Elahere in Ovarian Cancer
The immunohistochemistry test detects the folate receptor 1 protein, which is over-expressed in most ovarian cancers.
This Day11h
14.6 million Africans Die of Diabetes, Cardiovascular Conditions Before 70 Years
The Executive Vice-President, Diagnostics, Africa at Roche Diagnostics, Dr. Allan Pamba stated this in a statement to ...
Roche's VENTANA FOLR1 (FOLR1-2.1) RxDx Assay Gets CE Mark In Ovarian Cancer Treatment
Swiss drug major Roche Group (RHHBY) announced Monday that it has received CE Mark for its VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, ...
中国日报网11d
Roche Diagnostics opens new China head office, celebrates Group Open Innovation certification
Alongside opening the new offices, Roche Diagnostics' capabilities in China have been further recognised as it has been ...
FierceBiotech7d
Roche teams up with transcription factor trailblazer Flare in new $1.8B-plus cancer pact
Since the 2023 financing round, Flare’s lead program FX-909 has moved into a phase 1 clinical trial for patients with ...
GlobalData on MSN11d
Blood-based biomarker tests a ‘major leap’ in Alzheimer’s diagnostics
Offering a simpler alternative to PET scans and CSF analysis, blood-based biomarker tests could improve accessibility of ...
Roche Canada Announces New Informatics Jobs in Ontario's Life Sciences Sector
CNW/ - Hoffmann-La Roche Limited (Roche Canada) is pleased to announce, with support from the Government of Ontario through ...
中国日报网11d
Roche Diagnostics opens new China head office, celebrates Group Open Innovation certification
On November 8, 2024, Roche Diagnostics enhanced the company's long term commitment to China's local healthcare industry, to ultimately benefit patients in China and beyond, with the opening of its ...